AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34134777 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets (microcrystalline cellulose, coloring, magnesium stearate)
Number of subjects: 0
Study 34190716 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib 300 mg PO daily for 2 weeks
Number of subjects: 10
Study 34190716 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 33181643 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 132
Study 33181643 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 132
Study 33181643 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine
Number of subjects: 132
Study 33181643 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline (control)
Number of subjects: 132
Study 35081912 — intervention group
Group type: EXPERIMENTAL
Intervention: In-clinic group visits
Number of subjects: 0
Study 35081912 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone-based group visits
Number of subjects: 0
Study 35081912 — intervention group
Group type: COMPARATOR
Intervention: In-clinic individual visits
Number of subjects: 0
Study 32640881 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic rehabilitation
Number of subjects: 224
Study 32640881 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 224
Study 35857037 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox and conventional treatment
Number of subjects: 80
Study 35857037 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 80
Study 35857037 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 34772708 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung cancer screening using low-dose computed tomography (LDCT)
Number of subjects: 250
Study 34772708 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung cancer screening
Number of subjects: 250
Study 35702828 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine/naloxone (8 mg/2 mg to 24 mg/6 mg per day; flexible take-home dosing)
Number of subjects: 272
Study 35702828 — intervention group
Group type: COMPARATOR
Intervention: Oral methadone (≈60-120 mg/day; closely supervised)
Number of subjects: 272
Study 35702828 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine/naloxone
Number of subjects: 272
Study 35702828 — intervention group
Group type: COMPARATOR
Intervention: Oral methadone
Number of subjects: 272
Study 35702828 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 272
Study 32349893 — intervention group
Group type: EXPERIMENTAL
Intervention: Açaí juice (200 mL/day for 4 weeks)
Number of subjects: 30
Study 32349893 — intervention group
Group type: EXPERIMENTAL
Intervention: Juçara juice (200 mL/day for 4 weeks)
Number of subjects: 30
Study 36000960 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapular movement training (SMT)
Number of subjects: 64
Study 36000960 — intervention group
Group type: COMPARATOR
Intervention: Standardized exercises (SE)
Number of subjects: 64
Study 34443992 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordinative exercise (CE)
Number of subjects: 135
Study 34443992 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular exercise (CVE)
Number of subjects: 135
Study 34443992 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 135
Study 33108244 — intervention group
Group type: EXPERIMENTAL
Intervention: rhG-CSF combined with minimal-dose Dec (G-Dec group: 100 µg/m2 of rhG-CSF on days 0-5 and 5 mg/m2 of Dec on days 1-5)
Number of subjects: 204
Study 33108244 — intervention group
Group type: COMPARATOR
Intervention: no intervention (non-G-Dec group)
Number of subjects: 204
Study 33108244 — intervention group
Group type: EXPERIMENTAL
Intervention: rhG-CSF combined with minimal-dose Dec (G-Dec group)
Number of subjects: 204
Study 35682461 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue-strengthening exercise (TSE) consisting of compressing an air‐filled bulb between the tongue and hard palate for 30 min a day, 5 days a week, for 8 weeks
Number of subjects: 102
Study 35682461 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 102
Study 32223010 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver duct tape occlusion for up to 8 weeks or until warts disappear
Number of subjects: 100
Study 32223010 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy every 2 to 3 weeks for a maximum of four sessions or until warts disappear
Number of subjects: 100
Study 36241128 — intervention group
Group type: EXPERIMENTAL
Intervention: eRAPID
Number of subjects: 167
Study 36241128 — intervention group
Group type: EXPERIMENTAL
Intervention: chemoRT-eRAPID
Number of subjects: 167
Study 34348194 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing intervention (three 15 min essays)
Number of subjects: 100
Study 34348194 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 32591498 — intervention group
Group type: EXPERIMENTAL
Intervention: Six repeated ketamine infusions
Number of subjects: 54
Study 32591498 — intervention group
Group type: COMPARATOR
Intervention: Single ketamine infusion
Number of subjects: 54
Study 32591498 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (active placebo)
Number of subjects: 54
Study 34057603 — intervention group
Group type: EXPERIMENTAL
Intervention: Feed rail feeding
Number of subjects: 40
Study 34057603 — intervention group
Group type: COMPARATOR
Intervention: Manual gravity feeding (control)
Number of subjects: 40
Study 33607775 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenfu injection combined with sodium nitroprusside
Number of subjects: 0
Study 33607775 — intervention group
Group type: COMPARATOR
Intervention: Sodium nitroprusside alone
Number of subjects: 0
Study 35620919 — intervention group
Group type: EXPERIMENTAL
Intervention: α-difluoromethylornithine (DFMO) administered orally at a dosage of 500 mg/m2/day for up to 5 years.
Number of subjects: 0
Study 35620919 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group) administered orally for up to 5 years.
Number of subjects: 0
Study 35251575 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic rehabilitation nursing combined with WeChat publicity and education
Number of subjects: 92
Study 35251575 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing (Control group)
Number of subjects: 92
Study 32436761 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN)
Number of subjects: 13
Study 32436761 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 34614209 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoendocrine therapy (CT+E)
Number of subjects: 458
Study 34614209 — intervention group
Group type: COMPARATOR
Intervention: Endocrine therapy (E)
Number of subjects: 458
Study 33601378 — intervention group
Group type: EXPERIMENTAL
Intervention: Emollient plus cream (EC; Dermoflan®) applied once daily for 2 months
Number of subjects: 20
Study 33601378 — intervention group
Group type: COMPARATOR
Intervention: Placebo applied once daily for 2 months
Number of subjects: 20
Study 32424253 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop digital meditation intervention
Number of subjects: 0
Study 33970101 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia for 3 hr
Number of subjects: 60
Study 33970101 — intervention group
Group type: COMPARATOR
Intervention: Awake controls
Number of subjects: 60
Study 35254407 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebo
Number of subjects: 0
Study 35254407 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 33989526 — intervention group
Group type: EXPERIMENTAL
Intervention: Observed song patterns in 15 songbird species
Number of subjects: 15
Study 33989526 — intervention group
Group type: COMPARATOR
Intervention: Null models with randomly allocated constituents
Number of subjects: 15
Study 33989526 — intervention group
Group type: EXPERIMENTAL
Intervention: Canaries and zebra finches reared without auditory experiences
Number of subjects: 15
Study 33989526 — intervention group
Group type: EXPERIMENTAL
Intervention: Observed ML patterns in more than half of the cases
Number of subjects: 15
Study 33053609 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided seminal vesicle radiography (UGSVR) combining CT three-dimensional reconstruction (CT-TR)
Number of subjects: 32
Study 33053609 — intervention group
Group type: COMPARATOR
Intervention: Standard evaluation (control group)
Number of subjects: 32
Study 33297720 — intervention group
Group type: EXPERIMENTAL
Intervention: Head Start REDI intervention (evidence-based social-emotional learning program and coordinated interactive reading program)
Number of subjects: 356
Study 33297720 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 356
Study 35900474 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVIGATE (Early Intervention Services)
Number of subjects: 404
Study 35900474 — intervention group
Group type: COMPARATOR
Intervention: Community Care (CC)
Number of subjects: 404
Study 35900474 — intervention group
Group type: EXPERIMENTAL
Intervention: Sporadic cannabis use
Number of subjects: 404
Study 35900474 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent cannabis use
Number of subjects: 404
Study 34398020 — intervention group
Group type: EXPERIMENTAL
Intervention: TaperGuard ETT
Number of subjects: 50
Study 34398020 — intervention group
Group type: COMPARATOR
Intervention: Conventional ETT
Number of subjects: 50
Study 32912445 — intervention group
Group type: EXPERIMENTAL
Intervention: MitraClip plus guideline-directed medical therapy (GDMT)
Number of subjects: 614
Study 32912445 — intervention group
Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT) alone
Number of subjects: 614
Study 32912445 — intervention group
Group type: EXPERIMENTAL
Intervention: MitraClip
Number of subjects: 614
Study 35980448 — intervention group
Group type: EXPERIMENTAL
Intervention: CECT-based management
Number of subjects: 106
Study 35980448 — intervention group
Group type: COMPARATOR
Intervention: DL (Diagnostic Laparoscopy)
Number of subjects: 106
Study 33881221 — intervention group
Group type: EXPERIMENTAL
Intervention: Body fat percentage
Number of subjects: 0
Study 33881221 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body fat mass
Number of subjects: 0
Study 33881221 — intervention group
Group type: COMPARATOR
Intervention: Fat-free mass
Number of subjects: 0
Study 33881221 — intervention group
Group type: COMPARATOR
Intervention: Appendicular lean mass
Number of subjects: 0
Study 33881221 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 0
Study 32404390 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated digital brief intervention
Number of subjects: 800
Study 35331364 — intervention group
Group type: EXPERIMENTAL
Intervention: Disaster preparedness app (SiBen) for 2 weeks
Number of subjects: 80
Study 35331364 — intervention group
Group type: COMPARATOR
Intervention: Home visits and conventional education
Number of subjects: 80
Study 32819048 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.375% ropivacaine (20 ml)
Number of subjects: 62
Study 32819048 — intervention group
Group type: COMPARATOR
Intervention: 0.75% ropivacaine (10 ml)
Number of subjects: 62
Study 36173649 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral octreotide capsules (OOC) at 60 mg/day (with titration options to 40 or 80 mg/day)
Number of subjects: 40
Study 36173649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 33663235 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin add-on therapy
Number of subjects: 59
Study 33663235 — intervention group
Group type: COMPARATOR
Intervention: Conventional glucose-lowering therapy
Number of subjects: 59
Study 33152399 — intervention group
Group type: EXPERIMENTAL
Intervention: MLC tracking
Number of subjects: 17
Study 33152399 — intervention group
Group type: COMPARATOR
Intervention: ITV-based treatment
Number of subjects: 17
Study 35914418 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (six-week preparatory training programme using flipped classroom design and simulation-based workshops)
Number of subjects: 11
Study 35914418 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 11
Study 35914418 — intervention group
Group type: COMPARATOR
Intervention: Standard online and workplace training (control group)
Number of subjects: 11
Study 34148759 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Behavioral Treatment for Insomnia (BBTI)
Number of subjects: 56
Study 34148759 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 56
Study 32715482 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotational axis position (RAP) at heart level (P3) during SAHC
Number of subjects: 20
Study 32715482 — intervention group
Group type: COMPARATOR
Intervention: Rotational axis position (RAP) at above the head (P1) during SAHC
Number of subjects: 20
Study 36118631 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (suture pattern to modify gastric accommodation)
Number of subjects: 48
Study 36118631 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (suture pattern to reduce gastric volume)
Number of subjects: 48
Study 36118631 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (suture pattern to interrupt gastric emptying)
Number of subjects: 48
Study 36118631 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (all groups combined)
Number of subjects: 48
Study 36118631 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 48
Study 33000285 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafiltration rate (UFR)
Number of subjects: 68
Study 33000285 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrected serum calcium (cCa)
Number of subjects: 68
Study 33000285 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum phosphate (iP)
Number of subjects: 68
Study 33000285 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact parathyroid hormone (iPTH)
Number of subjects: 68
Study 33000285 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkaline phosphatase (ALP)
Number of subjects: 68
Study 33000285 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventricular septum thickness (IVST)
Number of subjects: 68
Study 33000285 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular mass indices (LVMI)
Number of subjects: 68
Study 33000285 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-averaged concentration of urea (TAC-urea)
Number of subjects: 68
Study 33000285 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 68
Study 33000285 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure during hemodialysis session
Number of subjects: 68
Study 36305694 — intervention group
Group type: EXPERIMENTAL
Intervention: COMBO
Number of subjects: 1111
Study 36305694 — intervention group
Group type: EXPERIMENTAL
Intervention: GOAL
Number of subjects: 1111
Study 36305694 — intervention group
Group type: EXPERIMENTAL
Intervention: USE
Number of subjects: 1111
Study 36305694 — intervention group
Group type: EXPERIMENTAL
Intervention: PLAN
Number of subjects: 1111
Study 36305694 — intervention group
Group type: COMPARATOR
Intervention: TRACK
Number of subjects: 1111
Study 33129630 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led program based on Pender's Health Promotion Model
Number of subjects: 62
Study 33129630 — intervention group
Group type: COMPARATOR
Intervention: Routine follow-ups (control group)
Number of subjects: 62
Study 35333028 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) intervention, 14 minutes per week for ten weeks
Number of subjects: 36
Study 35333028 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 33159819 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV infection
Number of subjects: 1128
Study 33159819 — intervention group
Group type: EXPERIMENTAL
Intervention: Syphilis infection
Number of subjects: 1128
Study 33159819 — intervention group
Group type: EXPERIMENTAL
Intervention: Schistosome infection
Number of subjects: 1128
Study 33159819 — intervention group
Group type: EXPERIMENTAL
Intervention: Transactional sex
Number of subjects: 1128
Study 33159819 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmed serological syphilis
Number of subjects: 1128
Study 33159819 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV and schistosome infection
Number of subjects: 1128
Study 34743136 — intervention group
Group type: EXPERIMENTAL
Intervention: Landmark-guided technique
Number of subjects: 300
Study 34743136 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve stimulation-guided technique
Number of subjects: 300
Study 34743136 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique
Number of subjects: 300
Study 34743136 — intervention group
Group type: COMPARATOR
Intervention: All techniques
Number of subjects: 300
Study 33273674 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% soybean plant
Number of subjects: 4
Study 33273674 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate addition of sugarcane
Number of subjects: 4
Study 33273674 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugarcane levels (25-50%)
Number of subjects: 4
Study 33273674 — intervention group
Group type: EXPERIMENTAL
Intervention: C50 soybean genotype
Number of subjects: 4
Study 34995296 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal feeding styles and practices at child age 5 months
Number of subjects: 474
Study 34995296 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal feeding styles and practices at child age 12 months
Number of subjects: 474
Study 34995296 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal feeding styles and practices at child age 24 months
Number of subjects: 474
Study 32284265 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma prevalence in 2002, 2006, and 2016
Number of subjects: 0
Study 32284265 — intervention group
Group type: EXPERIMENTAL
Intervention: Current wheeze prevalence
Number of subjects: 0
Study 32284265 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-induced wheeze prevalence
Number of subjects: 0
Study 32284265 — intervention group
Group type: EXPERIMENTAL
Intervention: Night dry cough prevalence
Number of subjects: 0
Study 32284265 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma likelihood by year
Number of subjects: 0
Study 33724542 — intervention group
Group type: EXPERIMENTAL
Intervention: Odanacatib (ODN) 50 mg/week
Number of subjects: 16071
Study 33724542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16071
Study 32128995 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-restricted diet (CRD) for 8 weeks
Number of subjects: 32
Study 32128995 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-restricted diet (CRD)
Number of subjects: 32
Study 32128995 — intervention group
Group type: COMPARATOR
Intervention: Fat-restricted diet (FRD)
Number of subjects: 32
Study 36203183 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Simulation (VS)
Number of subjects: 95
Study 36203183 — intervention group
Group type: COMPARATOR
Intervention: Usual Supervised Work (SW)
Number of subjects: 95
Study 33662902 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung-protective ventilation (LPV) with tidal volume 6 ml/kg PBW + PEEP 7 cmH2O
Number of subjects: 258
Study 33662902 — intervention group
Group type: COMPARATOR
Intervention: Nonprotective ventilation (control group) with tidal volume 9 ml/kg PBW without PEEP
Number of subjects: 258
Study 32055940 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (IH)
Number of subjects: 15
Study 32055940 — intervention group
Group type: COMPARATOR
Intervention: Continuous hypoxia (CH)
Number of subjects: 15
Study 36322001 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased physical activity program (n=40)
Number of subjects: 79
Study 36322001 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=39)
Number of subjects: 79
Study 33559435 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaoshen acupuncture method combined with electroacupuncture (EA)
Number of subjects: 76
Study 33559435 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture (EA) alone
Number of subjects: 76
Study 33559435 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Tiaoshen and EA)
Number of subjects: 76
Study 33559435 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaoshen group
Number of subjects: 76
Study 33223365 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-plane polyglactin mesh supported IBR (n=91)
Number of subjects: 190
Study 33223365 — intervention group
Group type: COMPARATOR
Intervention: Subpectoral IBR (n=117)
Number of subjects: 190
Study 34326500 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg
Number of subjects: 327
Study 33988519 — intervention group
Group type: EXPERIMENTAL
Intervention: Txt2Prevent (SMS text messaging intervention)
Number of subjects: 76
Study 33988519 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 76
Study 34310276 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT‐I)
Number of subjects: 32
Study 34310276 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Pain (CBT‐P)
Number of subjects: 32
Study 34310276 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 32
Study 34706856 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate
Number of subjects: 70
Study 34706856 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 70
Study 36343068 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 56
Study 36343068 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field therapy (PEMFT)
Number of subjects: 56
Study 36343068 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional physical therapy treatment)
Number of subjects: 56
Study 35510814 — intervention group
Group type: EXPERIMENTAL
Intervention: Transition workshop (ModuS‐T)
Number of subjects: 56
Study 35510814 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular medical care)
Number of subjects: 56